The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Regulatory News (HZD)

  • There is currently no data for HZD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Confidential submission of Form F-1 to SEC

4 Feb 2020 07:00

RNS Number : 8287B
Horizon Discovery Group plc
04 February 2020
 

 

 

Horizon Discovery Group plc

 

Confidential submission of Form F-1 to SEC relating to

proposed U.S. public offering

 

Cambridge, UK, 4 February 2020: Horizon Discovery Group plc (LSE: HZD) ("Horizon" "the Group" or "the Company") today announces that it has confidentially submitted a draft registration statement on Form F-1 with the Securities and Exchange Commission (the "SEC") relating to the proposed initial U.S. public offering of American depositary shares ("American Depositary Shares") representing its ordinary shares (the "Offering"). The number of American Depositary Shares to be offered and the price range for the proposed Offering have not yet been determined. Horizon expects to use the proceeds of the Offering for general corporate purposes. The Offering is expected to commence after the SEC completes its review process, subject to market and other conditions, and shareholders and potential investors should note that the potential Offering may or may not proceed.

This news release is being made pursuant to and in accordance with Rule 135 under the Securities Act of 1933, as amended, and does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

Ends

For further information from Horizon Discovery Group plc, please contact:

Horizon Discovery Group plc

Terry Pizzie, Chief Executive Officer

Jayesh Pankhania, Chief Financial Officer

Jon Davies, Head of Investor Relations

Tel: +44 (0) 1223 655 580

 

Numis Securities Limited (Broker and NOMAD)

Freddie Barnfield / Duncan Monteith

Tel: +44 (0) 207 260 1000

 

Consilium Strategic Communications (Financial Media and Investor Relations)

Mary-Jane Elliott / Matthew Neal / Melissa Gardiner

Tel: +44 (0) 20 3709 5700

Email: horizon@consilium-comms.com

 

Westwicke, an ICR Company (US Investor Relations)

Stephanie Carrington

Tel. +1 646-277-1282

Email: horizondiscovery@icrinc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUOAURRKUURUR
Date   Source Headline
8th Jul 20207:00 amRNSNotice of Trading Update & Capital Markets Webinar
26th Jun 20207:00 amRNSDirector/PDMR Shareholding
18th Jun 20201:00 pmRNSResult of AGM
18th Jun 20201:00 pmRNSDirector/PDMR Shareholding
5th Jun 20205:34 pmRNSHolding(s) in Company
4th Jun 202011:11 amRNSHoldings in Company
29th May 20207:00 amRNSDirector/PDMR Shareholding
22nd May 20207:00 amRNSAnnual Report and Notice of AGM
5th May 20205:46 pmRNSHolding(s) in Company
5th May 20201:34 pmRNSHolding(s) in Company
4th May 20201:58 pmRNSDirector/PDMR Shareholding
4th May 20207:00 amRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSBoard Changes
29th Apr 202010:43 amRNSHolding(s) in Company
27th Apr 20207:00 amRNSFull Year Unaudited Results 2019
17th Apr 20203:56 pmRNSResults of Placing
17th Apr 202011:00 amRNSProposed Placing and COVID-19 update
3rd Apr 202011:35 amRNSHolding(s) in Company
2nd Apr 20204:40 pmRNSSecond Price Monitoring Extn
2nd Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202010:56 amRNSHoldings in Company
27th Mar 20207:00 amRNSFull Year Results Deferral and COVID-19 Update
25th Mar 202011:20 amRNSHolding(s) in Company
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
17th Mar 202012:03 pmRNSPrice Monitoring Extension
27th Feb 202010:38 amRNSDirector/PDMR Shareholding
26th Feb 20207:00 amRNSPresentation Cowen Annual Health Care Conference
17th Feb 20207:00 amRNSTotal Voting Rights
14th Feb 20202:46 pmRNSHolding(s) in Company
4th Feb 20207:00 amRNSConfidential submission of Form F-1 to SEC
4th Feb 20207:00 amRNSTrading Update
27th Jan 20201:51 pmRNSBlock Listing Six Monthly Return
14th Jan 20207:00 amRNSUpdate on Base Editing Technology License
18th Dec 20197:00 amRNSPresentation at J.P. Morgan Healthcare Conference
16th Dec 201912:07 pmRNSSecond Price Monitoring Extn
16th Dec 201912:02 pmRNSPrice Monitoring Extension
13th Dec 20197:00 amRNSCollaboration with Mammoth Biosciences
4th Dec 201912:08 pmRNSSecond Price Monitoring Extn
4th Dec 201912:02 pmRNSPrice Monitoring Extension
4th Dec 20197:00 amRNSCompletion of Divestment of In Vivo Business Unit
8th Nov 20197:00 amRNSDivestment of In Vivo Business Unit
22nd Oct 20193:22 pmRNSAdditional Block Listing and Total Voting Rights
4th Oct 201912:07 pmRNSSecond Price Monitoring Extn
4th Oct 201912:02 pmRNSPrice Monitoring Extension
19th Sep 20193:30 pmRNSHolding(s) in Company
16th Sep 20197:00 amRNSHalf-year Report
12th Aug 201912:07 pmRNSSecond Price Monitoring Extn
12th Aug 201912:02 pmRNSPrice Monitoring Extension
26th Jul 20197:00 amRNSBlock Listing Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.